Total Payments
$1,355
2024 Payments
$226.52
Companies
18
Transactions
68
Medicare Patients
2,745
Medicare Billing
$167,425
Payment Breakdown by Category
Food & Beverage$1,355 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,355 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $229.44 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $194.17 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $176.30 | 12 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $106.49 | 6 | $0 (2023) |
| Boston Scientific Corporation | $98.05 | 6 | $0 (2024) |
| PFIZER INC. | $92.19 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $86.49 | 4 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $73.20 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $62.95 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $60.19 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $226.52 | 6 | PFIZER INC. ($78.48) |
| 2023 | $264.59 | 14 | Amgen Inc. ($78.08) |
| 2022 | $520.54 | 27 | Amgen Inc. ($124.68) |
| 2021 | $292.29 | 18 | BOSTON SCIENTIFIC CORPORATION ($66.96) |
| 2020 | $30.38 | 2 | Amarin Pharma Inc. ($17.96) |
| 2018 | $20.96 | 1 | Novartis Pharmaceuticals Corporation ($20.96) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $78.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $73.20 | General |
| Category: Genetic Disease | ||||||
| 08/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Cardiology | ||||||
| 06/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/30/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardiology | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: DIABETES | ||||||
| 06/01/2023 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CARDIOLOGY | ||||||
| 05/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: DIABETES | ||||||
| 05/10/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiology | ||||||
| 04/19/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Cardiovascular | ||||||
| 03/23/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Cardiovascular | ||||||
| 03/06/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiology | ||||||
| 03/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Genetic Disease | ||||||
| 02/06/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiology | ||||||
| 02/01/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: Cardiology | ||||||
| 11/03/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/27/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 898 | 1,008 | $185,734 | $45,277 |
| 2022 | 13 | 1,031 | 1,287 | $263,936 | $64,939 |
| 2021 | 6 | 362 | 425 | $77,466 | $24,781 |
| 2020 | 6 | 454 | 574 | $97,477 | $32,427 |
Total Patients
2,745
Total Services
3,294
Medicare Billing
$167,425
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $43,036 | $11,715 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 112 | $30,736 | $9,158 | 29.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 129 | 130 | $22,838 | $5,747 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 57 | $10,790 | $3,033 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $10,028 | $2,977 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 56 | $10,332 | $2,688 | 26.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 35 | $12,578 | $2,350 | 18.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 202 | 233 | $22,289 | $2,227 | 10.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 49 | 49 | $10,157 | $2,158 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,344 | $1,584 | 36.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 55 | 55 | $3,795 | $673.09 | 17.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 78 | 86 | $1,806 | $513.27 | 28.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 55 | 55 | $3,005 | $454.71 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 130 | $36,140 | $11,181 | 30.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 206 | 208 | $38,896 | $10,282 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 87 | 87 | $37,236 | $9,356 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 146 | $27,594 | $9,353 | 33.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 71 | 77 | $27,874 | $6,972 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 62 | 131 | $24,890 | $6,436 | 25.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 70 | 71 | $15,123 | $3,398 | 22.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 152 | 230 | $31,970 | $2,277 | 7.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $5,885 | $1,816 | 30.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 21 | $5,775 | $1,524 | 26.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 80 | 81 | $6,075 | $1,127 | 18.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 80 | 81 | $5,022 | $757.35 | 15.1% |
About Dr. Adrian Danchenko, MD
Dr. Adrian Danchenko, MD is a Cardiovascular Disease healthcare provider based in Cookeville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124027230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adrian Danchenko, MD has received a total of $1,355 in payments from pharmaceutical and medical device companies, with $226.52 received in 2024. These payments were reported across 68 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,355).
As a Medicare-enrolled provider, Danchenko has provided services to 2,745 Medicare beneficiaries, totaling 3,294 services with total Medicare billing of $167,425. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Cookeville, TN
- Active Since 07/20/2005
- Last Updated 10/25/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1124027230
Products in Payments
- Repatha (Biological) $229.44
- ENTRESTO (Drug) $176.44
- FARXIGA (Drug) $123.88
- ELIQUIS (Drug) $120.20
- JARDIANCE (Drug) $86.49
- VYNDAMAX (Drug) $78.48
- AMVUTTRA (Drug) $73.20
- WATCHMAN (Device) $66.96
- XARELTO (Drug) $62.95
- VERQUVO (Drug) $60.19
- BRILINTA (Drug) $52.42
- WATCHMAN FLX (Device) $31.09
- FABRAZYME (Biological) $25.18
- LifeVest (Device) $20.99
- MULTAQ (Drug) $20.75
- VITALPATCH RTM (Device) $19.44
- Vascepa (Drug) $17.96
- LEQVIO (Drug) $17.73
- Impella (Device) $17.07
- Edarbyclor (Drug) $15.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cookeville
Brent Klinkhammer, Md, MD
Cardiovascular Disease — Payments: $9,397
Cardiovascular Disease $9,397
Mariano Battaglia, M.d, M.D
Cardiovascular Disease — Payments: $3,146
Cardiovascular Disease $3,146
Ashley Nickerson, Do, DO
Cardiovascular Disease — Payments: $1,763
Cardiovascular Disease $1,763
Noel Torres Acosta, M.d, M.D
Cardiovascular Disease — Payments: $1,235
Cardiovascular Disease $1,235
Michael Lenhart, Md, MD
Cardiovascular Disease — Payments: $1,143
Cardiovascular Disease $1,143
Timothy Fournet, M.d, M.D
Cardiovascular Disease — Payments: $512.84
Cardiovascular Disease $512.84